| 000 | 01571 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514045601.0 | ||
| 264 | 0 | _c20021022 | |
| 008 | 200210s 0 0 eng d | ||
| 022 | _a1701-2163 | ||
| 024 | 7 |
_a10.1016/s1701-2163(16)30326-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLemay, André | |
| 245 | 0 | 0 |
_aThe relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice. _h[electronic resource] |
| 260 |
_bJournal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC _cSep 2002 |
||
| 300 |
_a711-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBreast Neoplasms _xetiology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
| 650 | 0 | 4 | _aEstrogens, Conjugated (USP) |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMedroxyprogesterone Acetate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aWomen's Health |
| 773 | 0 |
_tJournal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC _gvol. 24 _gno. 9 _gp. 711-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1701-2163(16)30326-7 _zAvailable from publisher's website |
| 999 |
_c12172367 _d12172367 |
||